News
Avid Bioservices Q3 2024 GAAP EPS $(0.09) Misses $(0.05) Estimate, Sales $33.800M Beat $33.452M Estimate
24 Apr 24
Earnings, Earnings Beats, Earnings Misses, News
Stephens & Co. Maintains Overweight on Avid Bioservices, Lowers Price Target to $12
11 Mar 24
News, Price Target, Analyst Ratings
9 Health Care Stocks Whale Activity In Today's Session
8 Mar 24
Options
S&P 500 Gains 1%; Kroger Earnings Top Views
7 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Biotech/Pharma Contract Service Provider Avid Bioservices Sees Lower Than Expected Q3 Sales, Sticks To Annual Guidance
7 Mar 24
Earnings, Equities, News, Guidance, Health Care, Financing, Movers, Trading Ideas, General
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
7 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Dow Gains 100 Points; Victoria's Secret Shares Plunge
7 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
12 Health Care Stocks Moving In Thursday's Intraday Session
7 Mar 24
Movers
Nasdaq Rises 100 Points; BJ's Wholesale Posts Weak Sales
7 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
RBC Capital Reiterates Outperform on Avid Bioservices, Maintains $7 Price Target
7 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Victoria's Secret Posts Weak Sales, Joins ADT, Avid Bioservices And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
7 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Avid Bioservices Prices Private Placement Of $160M 7.00% Convertible Senior Notes Due 2029
7 Mar 24
News
Avid Bioservices Announces Proposed $160M Private Placement Of Convertible Notes Due 2029
6 Mar 24
News, Offerings
Avid Bioservices Announces Certain Preliminary Q3 Results, Sees Revenue $33.8M Vs $34.19M Est.; Maintaining Revenue Guidance For FY24 Of $137M-$147M Vs $138.9M Est.
6 Mar 24
Earnings, News, Guidance
Press releases
Avid Bioservices (CDMO) Quantifies Wrongful Accounting Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities – Hagens Berman
25 Apr 24
News, Legal, Press Releases
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
24 Apr 24
Earnings, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
12 Apr 24
Press Releases
Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities – Hagens Berman
10 Apr 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
8 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
4 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
4 Apr 24
Press Releases
Investigation into Avid Bioservices, Inc. Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations - What Shareholders Need to Know!
3 Apr 24
News, Legal, Press Releases
Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities – Hagens Berman
1 Apr 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
31 Mar 24
News, Legal, Press Releases
Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities – Hagens Berman
28 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
27 Mar 24
Press Releases
CDMO LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMO
23 Mar 24
News, Legal, Press Releases
Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities – Hagens Berman
21 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Avid Bioservices Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
20 Mar 24
News, Legal, Press Releases
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation into Avid Bioservices, Inc. (NASDAQ: CDMO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
18 Mar 24
Press Releases
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
14 Mar 24
Small Cap, Press Releases
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
14 Mar 24
Press Releases
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
13 Mar 24
Small Cap, Press Releases
The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
13 Mar 24
Small Cap, Press Releases